Came NA - Search Results

1

A synonymous GATA2 variant underlying familial myeloid malignancy with striking intrafamilial phenotypic variability.

Fox LC, Tan M, Brown AL, Arts P, Thompson E, Ryland GL, Lickiss J, Scott HS, Poplawski NK, Phillips K, Came NA, James P, Ting SB, Ritchie DS, Szer J, Hahn CN, Schwarer A, Blombery P. Fox LC, et al. Among authors: came na. Br J Haematol. 2020 Sep;190(5):e297-e301. doi: 10.1111/bjh.16819. Epub 2020 Jun 3. Br J Haematol. 2020. PMID: 32488879 Free article. No abstract available.

2

Autologous peripheral blood stem cell transplantation for peripheral neuropathy secondary to monoclonal gammopathy of unknown significance.

Lee YC, Came N, Schwarer A, Day B. Lee YC, et al. Bone Marrow Transplant. 2002 Jul;30(1):53-6. doi: 10.1038/sj.bmt.1703582. Bone Marrow Transplant. 2002. PMID: 12105779

3

Carney DA, Westerman DA, Tam CS, Milner A, Prince HM, Kenealy M, Wolf M, Januszewicz EH, Ritchie D, Came N, Seymour JF. Carney DA, et al. Leukemia. 2010 Dec;24(12):2056-62. doi: 10.1038/leu.2010.218. Epub 2010 Oct 21. Leukemia. 2010. PMID: 20962860

4

Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trial.

Herbert KE, Demosthenous L, Wiesner G, Link E, Westerman DA, Came N, Ritchie DS, Harrison S, Seymour JF, Prince HM. Herbert KE, et al. Bone Marrow Transplant. 2014 Aug;49(8):1056-62. doi: 10.1038/bmt.2014.112. Epub 2014 Jun 2. Bone Marrow Transplant. 2014. PMID: 24887382 Clinical Trial.

5

Undetectable peripheral blood MRD should be the goal of venetoclax in CLL, but attainment plateaus after 24 months.

Lew TE, Anderson MA, Lin VS, Handunnetti SM, Came NA, Blombery P, Westerman DA, Wall M, Tam CS, Roberts AW, Seymour JF. Lew TE, et al. Among authors: came na. Blood Adv. 2020 Jan 14;4(1):165-173. doi: 10.1182/bloodadvances.2019000864. Blood Adv. 2020. PMID: 31935286 Free PMC article.

6

Computational flow cytometry provides accurate assessment of measurable residual disease in chronic lymphocytic leukaemia.

Nguyen PC, Nguyen V, Baldwin K, Kankanige Y, Blombery P, Came N, Westerman DA. Nguyen PC, et al. Br J Haematol. 2023 Aug;202(4):760-770. doi: 10.1111/bjh.18802. Epub 2023 Apr 13. Br J Haematol. 2023. PMID: 37052611

7

Evaluation of T-cell clonality by anti-TRBC1 antibody-based flow cytometry and correlation with T-cell receptor sequencing.

Nguyen PC, Nguyen T, Wilson C, Tiong IS, Baldwin K, Nguyen V, Came N, Blombery P, Westerman DA. Nguyen PC, et al. Br J Haematol. 2024 Mar;204(3):910-920. doi: 10.1111/bjh.19252. Epub 2023 Dec 14. Br J Haematol. 2024. PMID: 38098188

8

Immunophenotypic characterisation of acute myeloid leukaemia with UBTF tandem duplications.

Harrop S, Nguyen PC, Robinson S, Nguyen T, Tiong IS, Came N, Baldwin K, Nguyen V, Chan KL, Blombery P, Westerman D. Harrop S, et al. Br J Haematol. 2024 Mar 28. doi: 10.1111/bjh.19427. Online ahead of print. Br J Haematol. 2024. PMID: 38544472 No abstract available.

9

An atypical presentation of persistent polyclonal B-lymphocytosis with symptomatic splenomegaly and response to rituximab.

Blombery P, Came N, Maxwell E, Herbert K. Blombery P, et al. Pathology. 2013 Jun;45(4):437-40. doi: 10.1097/PAT.0b013e328360f04f. Pathology. 2013. PMID: 23635822 No abstract available.

10

The denominator variable in the quantitation of MRD in acute myeloid leukemia.

Came N, Westerman D, Juneja S. Came N, et al. Am J Hematol. 2015 Nov;90(11):E213-5. doi: 10.1002/ajh.24142. Epub 2015 Oct 12. Am J Hematol. 2015. PMID: 26251233 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page